Search research articles
Contact Us
Filters
Showing results (291-300 of 408) with videos related to
Page
of 41
Sort By:
Epilepsia
|
May 9, 2017
Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
Isabel Steinig, Felix von Podewils, Gabriel Möddel, et al.
Angewandte Chemie (International Ed. in English)
|
June 26, 2015
Covalent-Allosteric Kinase Inhibitors
Jörn Weisner, Rajesh Gontla, Leandi van der Westhuizen, et al.
Epilepsia
|
January 15, 2014
A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation study
Katja Menzler, Anke Hermsen, Katharina Balkenhol, et al.
Sarcoma
|
September 21, 2021
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology
Inna Schott, Sven-Thorsten Liffers, Farhad Farzaliyev, et al.
The Oncologist
|
March 4, 2023
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies
Emanuela Palmerini, John H Healey, Nicholas M Bernthal, et al.
British Journal of Cancer
|
June 18, 2021
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies
Sebastian Bauer, George D Demetri, Ensar Halilovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
International Journal of Cancer
|
March 19, 2019
Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)
Stefanie Jilg, Michael Rassner, Jacqueline Maier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2025
Phase 2 trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG trial)
Johanna Falkenhorst, Phillipp Ivanyi, Tom Schulz, et al.
The Lancet. Oncology
|
June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay, César Serrano, Michael C Heinrich, et al.
Page
of 41
Search research articles
Search
Showing results (291-300 of 408) with videos related to
Sort By:
Page
of 41
Epilepsia
|
May 9, 2017
Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
Isabel Steinig, Felix von Podewils, Gabriel Möddel, et al.
Angewandte Chemie (International Ed. in English)
|
June 26, 2015
Covalent-Allosteric Kinase Inhibitors
Jörn Weisner, Rajesh Gontla, Leandi van der Westhuizen, et al.
Epilepsia
|
January 15, 2014
A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation study
Katja Menzler, Anke Hermsen, Katharina Balkenhol, et al.
Sarcoma
|
September 21, 2021
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology
Inna Schott, Sven-Thorsten Liffers, Farhad Farzaliyev, et al.
The Oncologist
|
March 4, 2023
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies
Emanuela Palmerini, John H Healey, Nicholas M Bernthal, et al.
British Journal of Cancer
|
June 18, 2021
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies
Sebastian Bauer, George D Demetri, Ensar Halilovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
International Journal of Cancer
|
March 19, 2019
Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)
Stefanie Jilg, Michael Rassner, Jacqueline Maier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2025
Phase 2 trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG trial)
Johanna Falkenhorst, Phillipp Ivanyi, Tom Schulz, et al.
The Lancet. Oncology
|
June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay, César Serrano, Michael C Heinrich, et al.
Page
of 41